Gamelaya Institute News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gamelaya institute. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gamelaya Institute Today - Breaking & Trending Today

Production issues, hesitancy in Russia and failure abroad: Is the Sputnik vaccine unravelling?


Vladimir Putin visits a hospital in Moscow
When a vaccination centre opened in a high-end department store on Red Square at the start of the year, Moscow residents were queuing up to get their dose of the Russian-produced Sputnik V.
Now that queue has died down to a trickle, and shoppers passing by the pop-up vaccination hub on a recent weekday afternoon said they were in no rush to get the jab.
“I’m not even thinking about it,” said Svetlana Sharshunovich, 45, strolling through the Soviet-era GUM store with her son. “We don’t know enough about the virus or the vaccine. I take my vitamins and I live healthily, that’s enough.” ....

Saint Petersburg , Sankt Peterburg , United Kingdom , Sergei Rybakov , Vladimir Putin , Dmitry Medvedev , Svetlana Sharshunovich , Sergei Sobyanin , Gamelaya Institute , Doctor Alliance , European Medical Authority , Levada Centre , Red Square , Russian Produced Sputnik , President Vladimir Putin , President Dmitry Medvedev , துறவி பீட்டர்ஸ்பர்க் , ஒன்றுபட்டது கிஂக்டம் , விளாடிமிர் புட்டின் , டமிட்ரீ மெட்‌வெடெவ் , மருத்துவர் கூட்டணி , ஐரோப்பிய மருத்துவ அதிகாரம் , சிவப்பு சதுரம் , ப்ரெஸிடெஂட் விளாடிமிர் புட்டின் , ப்ரெஸிடெஂட் டமிட்ரீ மெட்‌வெடெவ் ,

AstraZeneca to test if its vaccine works better combined with Russia's Sputnik V


The collaboration with AstraZeneca may help boost confidence in Sputnik V, amid scepticism over the speed of its rollout and the scope and transparency of data from clinical trials. Russia’s defence ministry claims the vaccine is a victim of a foreign financed “information sabotage” campaign.
The Kremlin hailed Sputnik V as the world’s first registered coronavirus vaccine in August, when Russian regulators approved it before phase three trials had even begun.
“We believe the poor methodological quality, design flaws in the study, errors in data analysis, and poor description of the study cast doubt on the main conclusions about the safety and efficacy of the vaccine,” three vice-presidents of Russia’s Society for Evidence-Based Medicine said of the available Sputnik V test data. ....

United States , United Kingdom , Alex Azar , Kirill Dmitriev , Alexander Ginsburg , Anna Popova , Drug Administration , Russian Direct Investment Fund , Gamelaya Institute , Russia Society For Evidence , Russian Gamaleya Research , Gamaleya Institute , Oxford University , Evidence Based Medicine , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , அலெக்ஸ் அசார் , அலெக்சாண்டர் ஜின்ஸ்பர்க் , அண்ணா பாபூவ , ரஷ்ய நேரடி முதலீடு நிதி , ரஷ்யா சமூகம் க்கு ஆதாரம் , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் , ஆதாரம் அடிப்படையிலானது மருந்து ,